Overview
- Net sales increase by 8.1%, driven by double-digit growth in Healthcare and Life Science
- EBITDA pre up by 15.4%
- Forecast for sales and earnings raised following Versum acquisition
In the third quarter, we continued to resolutely implement our strategy. We substantially increased sales and earnings.
Quarterly Statement Q3 2019
Merck KGaA, Darmstadt, Germany Generates Profitable Growth in Q3 2019
PDF Download
Video: Financial Results Q3 2019
Overview of our third quarter financial results 2019.
Watch the videoRelated News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany Generates Profitable Growth in Q3 2019
Merck KGaA, Darmstadt, Germany generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019.
2019/11/14
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price